These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanisms of renal damage in plasma cell dyscrasias: an overview. Merlini G, Pozzi C. Contrib Nephrol; 2007; 153():66-86. PubMed ID: 17075224 [Abstract] [Full Text] [Related]
3. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress]. Bridoux F, Delbes S, Sirac C, Pourreau F, Puyade M, Desport E, Jaccard A, Fermand JP, Touchard G. Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725 [Abstract] [Full Text] [Related]
4. [Kidney damage in multiple myeloma and other monoclonal gammopathies]. Adam Z, Pour L, Krejcí M, Stĕpánková S, Svobodová I, Veselý K, Hájek R. Vnitr Lek; 2008 Sep; 54(9):847-61. PubMed ID: 18924346 [Abstract] [Full Text] [Related]
5. Monoclonal immunoglobulin deposition disease associated with membranous features. Komatsuda A, Masai R, Ohtani H, Togashi M, Maki N, Sawada K, Wakui H. Nephrol Dial Transplant; 2008 Dec; 23(12):3888-94. PubMed ID: 18596130 [Abstract] [Full Text] [Related]
11. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties]. Cagnoli L, Italian Society of Nephrology. G Ital Nefrol; 2003 Jul; 20 Suppl 24():S3-47. PubMed ID: 14666502 [Abstract] [Full Text] [Related]
12. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Bridoux F, Hugue V, Coldefy O, Goujon JM, Bauwens M, Sechet A, Preud'Homme JL, Touchard G. Kidney Int; 2002 Nov; 62(5):1764-75. PubMed ID: 12371978 [Abstract] [Full Text] [Related]